TIPARP and colitis: Since PARP7 is a negative regulator of AHR and IFN-I, and loss of PARP7 expression increases both AHR and IFN-I signaling, we used a DSS-induced colitis model to investigate the effect of PARP7 loss on DSS-induced intestinal inflammation.